Effect of CLK2 and SRPK1 KD in HBV-infected dHepaRG cells. by Florentin Pastor (19852287)

Rescue of 1C8 inhibitory effect by DYRK1A over-expression. by Florentin Pastor (19852287)

Toxicity assays of AZ191 in PHHs. by Florentin Pastor (19852287)

Comparative effects of AZ191 and DB18 in HBV-infected PHH. by Florentin Pastor (19852287)

Toxicity of DYRK1A and DYRK1B KD in HBV-infected dHepaRG cells. by Florentin Pastor (19852287)

Linear regressions of the distance between buoys (km) and the normalized dynamic time warping value for each pairwise buoy combination for 2021 (blue) and 2022 (gray). by Claire Stevens (11127729)

Over-expression of DYRK1A increases HBV RNA levels in HBV-infected dHepaRG cells. by Florentin Pastor (19852287)

Divergent effects of DYRK1A KD in HBV-infected PHH. by Florentin Pastor (19852287)

“…(B) Representative Western blot analysis of DYRK1A KD levels. (C) and (D) DYRK1A and HBV RNA analysis of a set of 3 independent experiments, each performed in triplicate, in which a decrease of HBV RNAs was observed. …”

DYRK1A over-expression increases the level of HBV nascent RNAs. by Florentin Pastor (19852287)

Effect of DYRK1B and DYRK1B_KR over-expression on HBV parameters. by Florentin Pastor (19852287)

Chemical inhibitors targeting DYRK1A and DYRK1B reduce HBV RNAs production. by Florentin Pastor (19852287)

Metabolic and molecular effects of high-fat diet (HFD). by Ping-yu Cai (12389929)

Effect of single or combined DYRK1A/DYRK1B KD in HBV-infected PHHs. by Florentin Pastor (19852287)

“…PHHs (+) and (-) refers to experiments in which an increase (+) or a decrease (-) of HBV RNAs levels was observed following DYRK1A KD (see <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0311655#pone.0311655.s007" target="_blank">S7 Fig</a>). …”

miR-150-5p inhibition modulates pyroptosis and FoxO3a/ARC signaling in ApoE^-/- mice. by Ping-yu Cai (12389929)

Therapeutic effects of miR-150-5p inhibition on ox-LDL-induced pyroptosis in RAW264.7 macrophages. by Ping-yu Cai (12389929)

Therapeutic effects of miR-150-5p inhibition on atherosclerotic lesion development. by Ping-yu Cai (12389929)

Dysregulation of miR-150-5p and its target FoxO3a in atherosclerosis (AS). by Ping-yu Cai (12389929)

Status (A) and duration (B) of breast feeding among participants. by Sara Saleh (6733619)

Chromatograms proved the selectivity of the proposed method. Red line: tissue spiked at the LOQ level; green line: blank tissue. Panel A: SIM and SIMA; panel B: LOV and LOVA. by Ewa Paszkowska (21246702)

<i>atb’’αβγδ</i> plants exhibit retarded development under calcium-deficient and ABA-supplemented conditions after germination. by Hyuk Sung Yoon (20208672)